Corrigendum to 'Antinociceptive effects of the selective non-peptide -opioid receptor agonist TAN-67 in diabetic mice'

By Kamei J.   Saitoh A.   Ohsawa M.   Suzuki T.   Misawa M.   Nagase H.   Kasuya Y.  

European Journal of Pharmacology, Vol. 280, Iss. 3, 1995-07 ,pp. : 347-347

Elsevier

Access to resources Recommend Favorite

Supraspinal 1 -opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice

By Kamei J.   Kawai K.   Mizusuna A.   Saitoh A.   Morita K.   Narita M.   Tseng L.F.   Nagase H.  

European Journal of Pharmacology, Vol. 322, Iss. 1, 1997-03 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

Novel developments with selective, non-peptidic kappa-opioid receptor agonists

By Barber A.   Gottschlich R.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1351-1368

Informa Healthcare

Access to resources Recommend Favorite

The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice

By Kamei J.   Ohsawa M.   Suzuki T.   Saitoh A.   Endoh T.   Narita M.   Tseng L.F.   Nagase H.  

European Journal of Pharmacology, Vol. 383, Iss. 3, 1999-11 ,pp. : 241-247

Elsevier

Access to resources Recommend Favorite

Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice

By Kamei J.   Ohsawa M.   Kashiwazaki T.   Nagase H.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite